GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Abingdon Health PLC (LSE:ABDX) » Definitions » Interest Coverage

Abingdon Health (LSE:ABDX) Interest Coverage : 0 (At Loss) (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Abingdon Health Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Abingdon Health's Operating Income for the six months ended in Dec. 2023 was £-1.46 Mil. Abingdon Health's Interest Expense for the six months ended in Dec. 2023 was £-0.03 Mil. did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Abingdon Health's Interest Coverage or its related term are showing as below:


LSE:ABDX's Interest Coverage is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 12.84
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Abingdon Health Interest Coverage Historical Data

The historical data trend for Abingdon Health's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Abingdon Health Interest Coverage Chart

Abingdon Health Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Interest Coverage
Get a 7-Day Free Trial - 3.34 - - -

Abingdon Health Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Abingdon Health's Interest Coverage

For the Diagnostics & Research subindustry, Abingdon Health's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abingdon Health's Interest Coverage Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Abingdon Health's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Abingdon Health's Interest Coverage falls into.



Abingdon Health Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Abingdon Health's Interest Coverage for the fiscal year that ended in Jun. 2023 is calculated as

Here, for the fiscal year that ended in Jun. 2023, Abingdon Health's Interest Expense was £-0.07 Mil. Its Operating Income was £-3.60 Mil. And its Long-Term Debt & Capital Lease Obligation was £0.93 Mil.

Abingdon Health did not have earnings to cover the interest expense.

Abingdon Health's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Here, for the six months ended in Dec. 2023, Abingdon Health's Interest Expense was £-0.03 Mil. Its Operating Income was £-1.46 Mil. And its Long-Term Debt & Capital Lease Obligation was £0.91 Mil.

Abingdon Health did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.


Abingdon Health  (LSE:ABDX) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Abingdon Health Interest Coverage Related Terms

Thank you for viewing the detailed overview of Abingdon Health's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.


Abingdon Health (LSE:ABDX) Business Description

Traded in Other Exchanges
N/A
Address
York Biotech Campus, Sand Hutton, York, GBR, YO41 1LZ
Abingdon Health PLC is a technology-enabled lateral flow diagnostics company. It provides rapid testing solutions to clients in healthcare and other industries. The firm's product ABC-19 is an antibody test for Covid-19 , and also produces tests covering areas such as self-test HIV, equine infection, human fertility, etc. Business operating segments includes; Contract Development comprises development work for third parties. Contract Manufacturing comprises contract development and manufacturing activities. Product Sales comprises the sale of ABC-19, Pocket Diagnostic products, PCRD tests and antibodies for research use. Key revenue comes from Contract Development segment. Geographically it operates and earns revenue from the UK, USA and Canada, Europe and the rest of the world.

Abingdon Health (LSE:ABDX) Headlines

No Headlines